A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma

Mise à jour : Il y a 4 ans
Référence : NCT01511913

Femme et Homme

Extrait

The purpose of this study is to examine the safety of Ipilimumab and patterns of use in the treatment of unresectable or metastatic melanoma in the post-approval setting.


Critère d'inclusion

  • Advanced Cutaneous Melanoma


Liens